Cargando…
Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression Studies
Despite significant advances in cancer diagnosis and treatment, osteosarcoma (OSA), an aggressive primary bone tumor, has eluded attempts at improving patient survival for many decades. The difficulty in managing OSA lies in its extreme genetic complexity, drug resistance, and heterogeneity, making...
Autores principales: | Nance, Rebecca L., Cooper, Sara J., Starenki, Dmytro, Wang, Xu, Matz, Brad, Lindley, Stephanie, Smith, Annette N., Smith, Ashley A., Bergman, Noelle, Sandey, Maninder, Koehler, Jey, Agarwal, Payal, Smith, Bruce F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031617/ https://www.ncbi.nlm.nih.gov/pubmed/35456486 http://dx.doi.org/10.3390/genes13040680 |
Ejemplares similares
-
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients
por: Agarwal, Payal, et al.
Publicado: (2021) -
Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
por: Smith, Ashley A., et al.
Publicado: (2022) -
Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment
por: Nance, Rebecca L., et al.
Publicado: (2023) -
Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines
por: Hogans, Madison D., et al.
Publicado: (2022) -
Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors
por: Sajib, Abdul Mohin, et al.
Publicado: (2020)